As shown in Figure 5A–C, FDX1 was preferably expressed at a higher level in ccRCC patients with either histological T stage < T2 or grade G1 + G2, indicating that FDX1 is a good prognostic factor in ccRCC progression. This evidence concerns the gene FDX1 and nonpapillary renal cell carcinoma.